Catalysts
PRODUCTS
-
When AST came to the table on the design for our new fill-finish isolator, one of the first areas AST engineers wanted to address was the usability and accessibility of the isolator and corresponding operations. With our customers’ point of view in mind, we wanted to address specific points of friction routinely encountered by operators and closely examine whether those friction points were necessary.
Does an isolator need to be ergonomically unfriendly to clean?
Should simple mechanisms like isolator doors be challenging to engage? (As much as one can appreciate exercise, no one wants to do “arm day” in cleanroom coveralls).
Does routine maintenance have to be time-consuming and laborious?
Many of these factors are accepted as par for the course in aseptic fill-finish manufacturing. Our question was, why?
-
Mycenax’s state-of-the-art biomanufacturing site is PIC/S GMP certified. Our highly qualified and well-trained team routinely manufactures high-quality biopharmaceutical products by mammalian cell culture and microbial fermentation processes. We continuously invest in our technologies and infrastructure to ensure that we constantly meet your evolving needs of today and tomorrow.
-
The IADA-2050CH is an integrated MMIC active doubler fabricated with GaAs Schottky diodes. This operates over a guaranteed 10 to 25 GHz input frequency range or a doubled output frequency range of 20 to 50 GHz.
-
The PE42447 is an SP4T RF switch that supports a frequency range from 10 MHz to 8 GHz. It delivers extremely low insertion loss and high linearity with high input power handling.
-
Ideal for small batch sizes, many format changes, or a wide variety of packaging materials – the BE4 reliably meets all requirements. It enables a highly efficient process thanks to the two-lane operation with a very small footprint. Thanks to the 100% modular concept of the Blister Expert platform, the BE4 can be upgraded to a high-speed solution at any time.
WHITE PAPERS AND CASE STUDIES
-
Large-Scale, 24/7 Mobile Quality Monitoring And Service Level Verification
Learn how CERN, the European Organization for Nuclear Research, created a reliable, cost-efficient, and fully compliant monitoring system for SLA verification with Android Probe and MNT solutions.
-
Designing Extrusions With Additional Processing
A medical device company worked to redesign a critical component and consolidate extrusion and secondary operations. The project was successfully completed in six months.
-
Tailored ISO 5 RABs Unit To Protect AST's Patented Filling Machine
Uncover how AST's satisfaction with Germfree's solution led to the acquisition of two additional units, showcasing the project's success and Germfree's expertise in tailored cleanroom solutions.
-
How Flatiron Supported The Beat AML® Master Clinical Trial
Find out how the Leukemia and Lymphoma Society's partnership with Flatiron Health helped improve the Beat AML® Master Clinical Trial's data management and accelerate trial timelines.
-
Elevating Purity: Racemizing Pharmaceutical Products In Flow Microreactors
Discover how our process development team resolved a racemization challenge by delivering a biologically active racemic mixture while maintaining compound purity.
-
Rehabilitation Of 72-inch Brick Combined Sanitary/Storm Sewer
When a 72-inch urban brick sewer suffered advanced crown deterioration, traditional excavation and CIPP methods were unviable. Discover how trenchless, spincast geopolymer mortar successfully executed a full structural restoration overnight, maintaining continuous daytime traffic and system flow.
-
Phenotypic Characterization Of Bleomycin-Induced Pulmonary Fibrosis Mod
To gain deeper biological insight, lung injury in this model has been further characterized through cellular phenotyping, gene expression analysis, and cytokine profiling.
-
Meeting 100% Recruitment 7 Months Ahead Of Schedule
Uncover the detailed outcomes of this extensive Phase 3 clinical trial on a new biosimilar for non-small cell lung cancer.
-
Lean Six Sigma Methodology Drives Cost Savings: 2 Success Stories
Unlock significant lab efficiency and financial gains. See how focused optimization of workflows and asset management led to substantial cost savings and reclaimed six-figure value in consumables.
-
A Comprehensive Solution For Critical Sample Analysis
Discover how Germfree Laboratories overcame challenges for the Royal Canadian Mounted Police by designing a mobile lab with advanced biocontainment and state-of-the-art communication systems.
-
How Digital Transformation In Sample Management Increases Efficiency
Explore a real-world example of how a dynamic and growing CDMO implemented a lab management system to improve efficiency and data integrity for their quality control sample management workflows.
-
Early-Stage Development In Rare Pediatric Oncology
Learn about the strategic approach a biotechnology company utilized to address significant hurdles in launching a Phase 1 clinical trial for a novel therapy targeting a rare pediatric cancer.
NEWS
-
Silo Pharma Expands Intellectual Property Portfolio With Patent Application For Exclusively Licensed Alzheimer's Drug4/28/2025
Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent application with the U.S. Patent and Trademark Office (USPTO) focused on the neurology drug SPC-14, an intranasal compound for the treatment of Alzheimer’s disease (AD) exclusively licensed to Silo Pharma from Columbia University.
-
SJW Infrastructure Improvement Progressing At Cambrian Tank Replacement Project5/29/2025
San Jose Water (“SJW” or “the Company”), a wholly owned subsidiary of H2O America, has made meaningful progress on its Cambrian Tank Replacement project, a major investment in the long-term reliability and seismic resilience of the Company’s water system.
-
Be Part of Photonics Future: CIOE 2025 Visitor Registration Live Now!4/9/2025
The 26th China International Optoelectronic Exposition (CIOE 2025) is set to take place from September 10–12, 2025, at the Shenzhen World Exhibition & Convention Center, spanning 240,000 square meters of exhibition space.
-
Aircraft Toilets Could Flush Out Spread Of Global Superbugs8/18/2025
Wastewater from aircraft toilets could provide a critical warning system for the global spread of antimicrobial resistant (AMR) superbugs, a silent pandemic that threatens to kill more people than cancer by 2050.
-
Pocket Alarm Detects And Records RF/Microwave Directed Energy Weapons, Nuclear Events, And Terrestrial Gamma Bursts5/8/2025
Ultraview Corp’s EM/GAMMALERT is a new pocket device that warns of RF/microwave jammer and directed energy weapon deployment1 - an emerging threat speculated as a modality in “Havana Syndrome”.
ABOUT
Catalysts
Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy. For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.
Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.
All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present. When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.
Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst. Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.
Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature. Applications of this technology include oil and petrochemical industries.